Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 8.11x is 50% above its 5-year average of 5.42x, near the high end of its 5-year range (-5.00x–10.80x).
0.21% below its 12-month average of 8.13x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 7.27x.
INTEREST COVERAGE RATIO
8.11x
INTEREST COVERAGE RATIO AVG TTM
8.13x
INTEREST COVERAGE RATIO AVG 3Y
6.75x
INTEREST COVERAGE RATIO AVG 5Y
5.42x
INTEREST COVERAGE RATIO AVG 10Y
4.31x
INTEREST COVERAGE RATIO AVG 15Y
5.00x
INTEREST COVERAGE RATIO AVG 20Y
6.42x
CURRENT VS TTM AVG
-0.21%
CURRENT VS 3Y AVG
+20.20%
CURRENT VS 5Y AVG
+49.61%
CURRENT VS 10Y AVG
+88.14%
CURRENT VS 15Y AVG
+62.12%
CURRENT VS 20Y AVG
+26.31%
SECTOR MEDIAN · HEALTHCARE
6.88x
median of 82 covered companies
CURRENT VS SECTOR MEDIAN
+17.79%
vs the sector median at left
AstraZeneca PLC
Market Cap
$248.50B
Interest Coverage Ratio
8.11x
TTM Avg
8.13x
3Y Avg
6.75x
5Y Avg
5.42x
Market Cap
$224.13B
Interest Coverage Ratio
5.71x
TTM Avg
5.17x
3Y Avg
6.77x
5Y Avg
10.10x
Market Cap
$206.27B
Interest Coverage Ratio
3.88x
TTM Avg
3.09x
3Y Avg
3.93x
5Y Avg
4.89x
Market Cap
$197.12B
Interest Coverage Ratio
30.34x
TTM Avg
54.30x
3Y Avg
123.94x
5Y Avg
139.58x
Market Cap
$179.83B
Interest Coverage Ratio
11.43x
TTM Avg
6.56x
3Y Avg
7.26x
5Y Avg
7.18x
Market Cap
$179.68B
Interest Coverage Ratio
23.60x
TTM Avg
17.46x
3Y Avg
17.67x
5Y Avg
16.77x
Market Cap
$338.62B
Interest Coverage Ratio
14.34x
TTM Avg
11.95x
3Y Avg
16.17x
5Y Avg
26.28x
Market Cap
$156.67B
Interest Coverage Ratio
5.78x
TTM Avg
5.55x
3Y Avg
10.96x
5Y Avg
11.04x
Market Cap
$355.08B
Interest Coverage Ratio
4.74x
TTM Avg
6.50x
3Y Avg
9.14x
5Y Avg
10.75x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AstraZeneca PLC (AZN) | $248.50B | 8.11x | 8.13x | 6.75x | 5.42x |
| Thermo Fisher Scientific Inc. (TMO)vs › | $224.13B | 5.71x | 5.17x | 6.77x | 10.10x |
| Amgen Inc. (AMGN)vs › | $206.27B | 3.88x | 3.09x | 3.93x | 4.89x |
| Novo Nordisk A/S (NVO)vs › | $197.12B | 30.34x | 54.30x | 123.94x | 139.58x |
| Gilead Sciences, Inc. (GILD)vs › | $179.83B | 11.43x | 6.56x | 7.26x | 7.18x |
| Abbott Laboratories (ABT)vs › | $179.68B | 23.60x | 17.46x | 17.67x | 16.77x |
| Roche Holding AG (RHHBY)vs › | $338.62B | 14.34x | 11.95x | 16.17x | 26.28x |
| Pfizer Inc. (PFE)vs › | $156.67B | 5.78x | 5.55x | 10.96x | 11.04x |
| UnitedHealth Group Incorporated (UNH)vs › | $355.08B | 4.74x | 6.50x | 9.14x | 10.75x |
| Danaher Corporation (DHR)vs › | $141.50B | 19.38x | 19.02x | 23.18x | 23.65x |
Interest Coverage
8.1x
Debt/Equity
0.64
Current Ratio
0.89
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 7.27x |
| 2026-03-31 | 10.80x |
| 2025-12-31 | 6.31x |
| 2025-09-30 | 8.26x |
| 2025-06-30 | 7.99x |
| 2025-03-30 | 10.53x |
| 2024-12-31 | 4.75x |
| 2024-09-30 | 4.61x |
| 2024-06-30 | 6.20x |
| 2024-03-31 | 7.54x |
| 2023-12-31 | 2.77x |
| 2023-09-30 | 4.98x |
| 2023-06-30 | 5.70x |
| 2023-03-31 | 6.98x |
| 2022-12-31 | 3.18x |
| 2022-09-30 | 3.67x |
| 2022-06-30 | 1.73x |
| 2022-03-31 | 2.61x |
| 2021-12-31 | -0.94x |
| 2021-09-30 | -5.00x |
| 2021-06-30 | 3.46x |
| 2021-03-31 | 6.25x |
| 2020-12-31 | 5.18x |
| 2020-09-30 | 3.61x |
| 2020-06-30 | 3.90x |
| 2020-03-31 | 3.67x |
| 2019-12-31 | 1.80x |
| 2019-09-30 | 2.14x |
| 2019-06-30 | 1.37x |
| 2019-03-31 | 2.99x |
| 2018-12-31 | 3.79x |
| 2018-09-30 | 2.34x |
| 2018-06-30 | 2.03x |
| 2018-03-31 | 2.03x |
| 2017-12-31 | 4.26x |
| 2017-09-30 | 2.75x |
| 2017-06-30 | 2.06x |
| 2017-03-31 | 2.70x |
| 2016-12-31 | 7.34x |
| 2016-09-30 | 2.90x |
| 2016-06-30 | 0.89x |
| 2016-03-31 | 3.19x |
| 2015-12-31 | 4.25x |
| 2015-09-30 | 4.76x |
| 2015-06-30 | 3.34x |
| 2015-03-31 | 3.57x |
| 2014-12-31 | -1.34x |
| 2014-09-30 | 2.29x |
| 2014-06-30 | 4.38x |
| 2014-03-31 | 3.92x |
| 2013-12-31 | -4.41x |
| 2013-09-30 | 13.33x |
| 2013-06-30 | 9.92x |
| 2013-03-31 | 12.15x |
| 2012-12-31 | 8.81x |
| 2012-09-30 | 15.97x |
| 2012-06-30 | 13.94x |
| 2012-03-31 | 16.36x |
| 2011-12-31 | 8.99x |
| 2011-09-30 | 17.33x |
| 2011-06-30 | 12.20x |
| 2011-03-31 | 13.60x |
| 2010-12-31 | 9.38x |
| 2010-09-30 | 8.88x |
| 2010-06-30 | 12.49x |
| 2010-03-31 | 14.18x |
| 2009-12-31 | 7.99x |
| 2009-09-30 | 10.79x |
| 2009-06-30 | 8.46x |
| 2009-03-31 | 11.59x |
| 2008-09-30 | 8.03x |
| 2008-06-30 | 7.32x |
| 2008-03-31 | 6.07x |
| 2007-09-30 | 5.76x |
| 2007-06-30 | 8.93x |
| 2007-03-31 | 14.47x |
| 2006-09-30 | 15.04x |
| 2006-06-30 | 17.47x |
| 2006-03-31 | 14.97x |
| 2005-09-30 | 4.56x |
| 2005-03-31 | 16.90x |
